MedTrace Logo

The Use of Continuous Wound Infusion Analgesia in Total Knee Arthroplasty

NCT00724074 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-07-29

No results posted yet for this study

Summary

The main purpose of this study is to determine if there is improvement in pain and other patient outcomes when using a continuous wound analgesia system after total knee replacement, compared to usual methods of pain control. Another purpose is to determine if the system makes it easier for nurses to care for these patients.

Conditions

  • Total Knee Arthroplasty

Interventions

DEVICE

On-Q PainBuster with Bupivacaine

On-Q PainBuster continuous wound infusion analgesia system, using bupivacaine as the local anaesthetic

DEVICE

Usual Care

Usual Care

Sponsors & Collaborators

  • Capital Health, Canada

    lead OTHER

Principal Investigators

  • Gordon Arnett, MD · Capital Health, Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00724074 on ClinicalTrials.gov